Corpus Intelligence IC Memo — WAYNE HOSPITAL COMPANY 2026-04-26 15:54 UTC
IC Memo — WAYNE HOSPITAL COMPANY
Investment Committee Memorandum | OH | 43 beds | Grade C | EBITDA uplift $4.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WAYNE HOSPITAL COMPANY

CCN 360044 | DARKE, OH | 43 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WAYNE HOSPITAL COMPANY is a 43-bed under-performing / distressed in DARKE, OH with $59.1M in net patient revenue and a -23.0% operating margin. The hospital serves a payer mix of 33.5% Medicare, 3.7% Medicaid, and 62.9% commercial.

Thesis: Turnaround. Our ML models identify $4.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -23.0% to -15.6% (+736bps).

Net Revenue HCRIS$59.1M
Current EBITDA COMPUTED$-13.6M
Operating Margin COMPUTED-23.0%
Occupancy HCRIS23.7%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS33.5%
Distress Probability ML54.3%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
114
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -23.0% places it below the state median. Among 114 size-comparable peers (22-86 beds), the median margin is -1.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-86), prioritizing same-state peers. 114 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WAYNE HOSPITAL COMPANY (Target)OH43$59.1M-23.0%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
OBLENESS MEMORIAL HOSPITALOH67$160.9M29.9%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
FISHER-TITUS MEDICAL CENTEROH78$148.3M-6.9%
WESTERN RESERVE HOSPITALOH83$147.6M-9.3%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$720K+122bp9mo
Clean Claim Rate88.0%96.0%$38K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.2M
Denial Rate Reduction
$1.2M
A/R Days Reduction
$720K
Clean Claim Rate
$38K
Total EBITDA Uplift$4.4M
Current EBITDA$-13.6M
+ RCM Uplift+$4.4M
Pro Forma EBITDA$-9.3M
Current Margin-23.0%
Pro Forma Margin-15.6%
WC Released (1x)$2.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-20.9M$-46.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-20.9M$-57.6M0.00x-100.0%
Bull Case9.0x11.0x$-18.8M$-50.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-18.8M$-60.2M0.00x-100.0%
Bear Case11.0x10.0x$-23.0M$-61.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-23.0M$-74.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 23.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 114 hospitals with 22-86 beds
  • Same-state prioritization (n=115)
  • Comp margins: P25=-11.5% / P50=-1.6% / P75=10.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.